Pacific Biosciences of California Inc. sell Barclays PLC
Start price
11.05.26
/
50%
€1.18
Target price
11.05.27
€1.28
Performance (%)
-12.14%
Price
12:34
€1.04
Summary
This prediction is currently active. The price of Pacific Biosciences of California Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.14%. This prediction currently runs until 11.05.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacific Biosciences of California Inc. | 4.741% | 4.741% |
| iShares Core DAX® | -1,59 % | 5,03 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % |
| iShares S&P 500 | -3,23 % | 0,47 % |
Comments by Barclays_PLC for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California (PACB) had its price target raised by Barclays PLC from $1.00 to $1.50. They now have an "underweight" rating on the stock.
Ratings data for PACB provided by MarketBeat
Stopped prediction by Barclays_PLC for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.28
14.04.26
14.04.26
€0.85
14.04.27
14.04.27
-19.57%
12:34
12:34
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.30
06.03.26
06.03.26
€1.29
06.03.27
06.03.27
-16.86%
12:34
12:34